Skip to content

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01953380
Acronym
ISICA-13
Enrollment
400
Registered
2013-10-01
Start date
2013-10-31
Completion date
2016-09-30
Last updated
2017-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatitis, Allergic Contact

Keywords

Intervention Studies, Eczema, Randomized Controlled Trial, Knowledge, Quality of Life

Brief summary

The purpose of this study is to determine whether extended information given to patients with contact allergy improves knowledge, treatment efficacy and daily functioning.

Interventions

Sponsors

Region Skane
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with suspected contact allergy * Age above 18 years * Participants have given informed consent

Exclusion criteria

* Mental or language disabilities

Design outcomes

Primary

MeasureTime frameDescription
knowledgeone year after inclusionknowledge about specific contact allergies and exposure, assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.

Secondary

MeasureTime frameDescription
clinical improvementone year after inclusionassessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.
quality of lifeone year after inclusionassessed by questionnaire, Dermatology Life Quality Index (DLQI).
effect on daily functioningone year after inclusionassessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and Dermatology Life Quality Index (DLQI).

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026